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Blood oxygenationCalibration of the BOLD signal is potentially of great value in providing a closer measure of the underlying
changes in brain function related to neuronal activity than the BOLD signal alone, but current approaches
rely on an assumed relationship between cerebral blood volume (CBV) and cerebral blood ﬂow (CBF). This
is poorly characterised in humans and does not reﬂect the predominantly venous nature of BOLD contrast,
whilst this relationship may vary across brain regions and depend on the structure of the local vascular
bed. This work demonstrates a new approach to BOLD calibration which does not require an assumption
about the relationship between cerebral blood volume and cerebral blood ﬂow. This method involves repeat-
ing the same stimulus both at normoxia and hyperoxia, using hyperoxic BOLD contrast to estimate the rela-
tive changes in venous blood oxygenation and venous CBV. To do this the effect of hyperoxia on venous blood
oxygenation has to be calculated, which requires an estimate of basal oxygen extraction fraction, and this can
be estimated from the phase as an alternative to using a literature estimate. Additional measurement of the
relative change in CBF, combined with the blood oxygenation change can be used to calculate the relative
change in CMRO2 due to the stimulus. CMRO2 changes of 18±8% in response to a motor task were measured
without requiring the assumption of a CBV/CBF coupling relationship, and are in agreement with previous
approaches.
© 2012 Elsevier Inc. All rights reserved.Introduction
Blood oxygenation level dependent (BOLD) contrast is widely
used in functional magnetic resonance imaging (fMRI) to monitor
brain function. However, the BOLD signal does not provide a direct
measurement of brain function, but rather it monitors the
haemodynamic response to changes in the underlying brain func-
tion. As a result the BOLD signal is blurred both spatially and tempo-
rally with respect to the underlying changes in neuronal function,
and the amplitude of the BOLD signal has a complex, indirect rela-
tionship on the amplitude of the neuronal activity, which depends
amongst other things on the local vascular structure and reactivity
(Boynton et al., 1996; Buxton et al., 1998; Friston et al., 1998;
Turner, 2002; Shmuel et al., 2007). These vascular confounds restrict
the conclusions that can be drawn from a BOLD experiment, particu-
larly in situations where either the baseline cerebral blood ﬂow
(CBF) and cerebral blood volume (CBV), or the capacity of the
cerebral vasculature to respond may be altered, such as in phar-
macological studies or some pathologies. Baseline and dynamicic Resonance Centre, University
, United Kingdom. Fax: +44
river).
rights reserved.haemodynamic properties will combine, along with the cerebral
metabolic rate of oxygen consumption (CMRO2), to determine
the amplitude of a BOLD signal response to changes in brain
function.
BOLD contrast depends primarily on changes in venous blood
oxygenation (Y) and venous cerebral blood volume (vCBV) (Ogawa
et al., 1993), and in turn, Y depends on CMRO2 and CBF, whilst the
vCBV is thought to be coupled to CBF (Grubb et al., 1974; Buxton et
al., 1998). Thus the BOLD signal depends on the changes in vCBV,
CBF and CMRO2.
CMRO2 is closely related to tissue energy demand (Rothman et al.,
1999), so is expected to provide a more direct measure of underlying
brain function than the BOLD signal, as it is less affected by local
haemodynamic properties. Task related changes in CMRO2 have previ-
ously been calculated by measuring BOLD and CBF changes in response
to a task (Davis et al., 1998). This approach requires knowledge of a cal-
ibration parameter, which is the BOLD signal change that would be
achieved if the venous blood volume were fully oxygenated. This cali-
bration parameter can be calculated using measured BOLD and CBF
changes in response to hypercapnia (Davis et al., 1998), or by using
BOLD changes in response to hyperoxia combined with a model esti-
mating the effect of hyperoxia on venous blood oxygenation (Chiarelli
et al., 2007a).
Regardless of whether hypercapnia or hyperoxia is used, this tech-
nique assumes that CBV is coupled to CBF for steady state conditions,
instead of directly measuring CBV. This coupling relationship was
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law relationship, such that
CBV∝CBFα ; ð1Þ
where α=0.38. Results subsequently obtained in humans suggested
that α=0.29 (Ito et al., 2003). However, this relationship refers to the
total CBV, whereas the BOLD signal arises primarily from the vascular
component containing deoxygenated haemoglobin (dHb) (i.e. vCBV
corresponding to veins and venules). Furthermore, vCBV has been
shown to increase relatively less than total CBV, in response to both
hypercapnia (Lee et al., 2001) and forepaw stimulation (Kim et al.,
2007) in rats. The coupling relationship between vCBV and CBF has
been measured in humans as α=0.23 during a combined motor
and visual task (Chen and Pike, 2009) and α=0.18 in response to hy-
percapnia (Chen and Pike, 2010), indicating that using the total CBV
rather than vCBV coupling relationship for calibrated BOLD will lead
to an underestimation of CMRO2 (Chen and Pike, 2009). Nonetheless
the coupling between vCBV and CBF remains poorly characterised in
humans, and may vary with brain region and in pathology.
In this work we propose a new approach to BOLD calibration,
using BOLD contrast on hyperoxia and normoxia, to calculate the rel-
ative change in venous CBV and Y due to the stimulus, avoiding the
need to make any assumption about the coupling between vCBV
and CBF.
Theory
Hyperoxia causes an increase in cerebral venous blood oxygena-
tion (Yv), providing a BOLD contrast which has previously been
used to measure both absolute resting vCBV (Bulte et al., 2007a)
and the fractional change in vCBV in response to a task (Blockley et
al., 2012). It will be shown that if the same task is performed at
both normoxia and hyperoxia then the relative change in Yv due to
the task can also be measured, assuming that hyperoxia has no effectTable 1
Table of parameters.
Parameter Description
Y Blood oxygenation fraction
(haemoglobin oxygen saturation fraction)
Q Deoxygenated haemoglobin
(dHb) fraction (=1−Y)
Q0 Normoxia, resting Q
ΔQh Absolute change in Q upon hyperoxia
qh Relative change in Q upon hyperoxia
(such that ΔQh=Q0·qh)
ΔQact Absolute change in Q due to the motor task
qact Relative change in Q due to the motor
task (such that ΔQact=Q0·qact)
CBF Cerebral blood ﬂow
rCBF Relative change in CBF due to the motor
task (rCBF=ΔCBF/CBF0)
CBV Cerebral blood volume
vCBV Venous cerebral blood volume
rvCBV Relative change in vCBV due to the motor
task (rvCBV=ΔvCBV/vCBV0)
CMRO2 Cerebral metabolic rate of oxygen
consumption
rCMRO2 Relative change in CMRO2 due to
the motor task
(rCMRO2=ΔCMRO2/CMRO2,0)
α Coupling relationship between CBV
and CBF (see Eq. (1))
β Power law relationship relating
extravascular transverse relaxation to Y
M Calibration parameter, as used in previous
BOLD calibration studieson either CBF or CMRO2. If the change in CBF due to the task is also
measured, then the relative change in CMRO2 (rCMRO2) due to the
task can be calculated (Davis et al., 1998) without assuming the rela-
tionship between vCBV and CBF.
Table 1 lists the parameters used in the following description of
the method.
Model for calculating relative task-related CMRO2 changes
An analytical model is used to describe the effect of hyperoxia on
tissue R2*, (Yablonskiy and Haacke, 1994).
R2 ¼ kV 1−Yð Þ þ R2;0 ð2Þ
where R2,0* is the transverse relaxation rate of tissue containing only
fully oxygenated blood vessels, Y is the blood haemoglobin oxygen
saturation fraction and V is the volume fraction occupied by blood
vessels. The term k is a constant arising from an extravascular signal
model, based on the static dephasing regime of spins located around
randomly orientated blood vessels:
k ¼ 4
3
πΔχ Hbtot½ B0 ð3Þ
where the 4π/3 term describes the effect of vessels with random ori-
entation, Δχ is the susceptibility of deoxygenated haemoglobin rela-
tive to tissue, [Hbtot] is the total haemoglobin concentration and B0 is
the static magnetic ﬁeld. This model assumes a linear relationship be-
tween R2* and deoxygenated haemoglobin fraction (β=1 in Davis
model (Davis et al., 1998)) which is more appropriate for 7 T
(Yablonskiy and Haacke, 1994; Driver et al., 2010; Croal et al., 2012a).
The venous dHb fraction Q is deﬁned such that Q=(1−Yv) and
Q0 denotes the normoxic rest condition (which is also equivalent to
oxygen extraction fraction (OEF)). Hyperoxia increases venous oxy-
genation Yv, such that on hyperoxia Q=(Q0+ΔQh)=Q0(1+qh),
where ΔQh is the absolute change in venous dHb fraction due to
hyperoxia and qh is the relative change in venous dHb due to
hyperoxia. Note that since hyperoxia will cause an increase in Yv,
ΔQh and qh will be negative. An analogous term qact can be deﬁned
for the relative change in Q due to task related changes in CMRO2
and CBF. Therefore, the venous dHb fraction during a task performed
at hyperoxia is Q=(Q0+ΔQh+ΔQact)=Q0(1+qh+qact), assuming
that the amount of oxygen extracted by the capillary bed is indepen-
dent of hyperoxia at steady state (i.e. qact is the same at normoxia and
hyperoxia).
The transverse relaxation rates during the neuronal activation
R2,act* and rest R2,rest* at a given level of hyperoxia (qh), can be modelled
as
R2;rest qhð Þ ¼ kV0Q0 1þ qhð Þ þ R2;0 ð4Þ
R2;act qhð Þ ¼ k V0 þ ΔVactð ÞQ0 1þ qh þ qactð Þ þ R2;0
¼ k V0 þ ΔVactð ÞQ0 1þ qhð Þ þ k V0 þ ΔVactð ÞQ0qact þ R2;0
ð5Þ
where V0 is the resting vCBV and ΔVact is the absolute change in
venous CBV due to neuronal activation. R2,0* is the transverse
relaxation rate of the tissue neglecting any venous effects, and
includes effects of shimming. The method for estimating qh is
discussed in Estimating qh theory section. If R2,act* and R2,rest*
are measured for two or more values of qh then the gradient of
a plot of R2,rest* versus (1+qh) (Fig. 1a) will be kV0Q0, which is
the calibration constant M used in previous calibrated BOLD ex-
periments (Davis et al., 1998; Chiarelli et al., 2007a). The gradient
of the plot of R2,act* versus (1+qh) (Fig. 1a) is k(V0+ΔVact)Q0,
which will be referred to as M′. The difference in intercepts of
the rest and activation curves is k(V0+ΔVact)Q0qact, which can
Fig. 1. (a) A schematic diagram of R2,rest* and R2,act* plotted against venous blood oxygenation, indicating the BOLD signal change on normoxia (open arrow) and hyperoxia (solid arrow).
The linear ﬁts shown are used to calculate rvCBV and qact as described in the Theory section. (b) Simulated relationship between SaO2 and SvO2 (=1−Q) and PaO2. The broken lines
indicate arterial and venous oxygen saturation for 110 mm Hg (~21% O2, normoxia) and 500 mm Hg (~60% O2). Values used in this simulation are PaO2,0=110 mm Hg, OEF=0.4,
ϕ=1.34 ml(O2)/g, [Hb]=15 g/dlblood and ε=0.0031 ml/(dlblood·mm Hg).
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gradients gives the relative venous CBV (rvCBV) change on acti-
vation:
M′
M
¼ 1þ ΔVact
V0
 
¼ 1þ rvCBVð Þ: ð6Þ
If the relative change in CBF (rCBF) on activation can be measured
(e.g. using arterial spin labelling (ASL)), then Fick's principle can be
combined with the value of qact to estimate the relative change in
CMRO2 (rCMRO2):
1þ rCMRO2ð Þ ¼ 1þ qactð Þ 1þ rCBFð Þ: ð7Þ
To summarise, this method does not assume a coupling relation-
ship between CBV and CBF (Grubb et al., 1974), but does assume neg-
ligible vasoconstriction due to hyperoxia (which is reasonable in the
case of normocapnic hyperoxia (Croal et al., 2012b)) and that oxygen
consumption is independent of hyperoxia so that qact is the same at
normoxia and hyperoxia (an area that needs further investigation).
This approach also assumes that the haematocrit remains constant
both during hyperoxia and the motor task. Furthermore to create
the plots described above, qh, the relative change in venous dHb
due to hyperoxia, must be known; a method for determining qh is de-
scribed in the next section.
Estimating qh
During hyperoxic periods, arterial oxygen partial pressure (PaO2)
is increased, with most of this extra oxygen being dissolved in arterial
plasma, since arterial haemoglobin is already close to being fully sat-
urated at normoxia. Oxygen dissociation in blood is described by a
widely accepted model (Severinghaus, 1979). At 310 K and a pH of
7.4, the relationship between arterial haemoglobin oxygen saturation
(SaO2) and PaO2 is
SaO2 ¼
23;400
PaO2
3 þ 150PaO2
−1
 −1
; ð8Þ
plotted in Fig. 1b. Here end-tidal PO2 (PETO2) was used to estimate
PaO2 (i.e. PETO2=PaO2) assuming that arterial blood gases are in
equilibrium with alveolar gas. This assumption is not true in general
as there are partial pressure gradients for oxygen between exhaled
gas and alveolar gas due to non-uniform alveolar distribution of in-
haled gas, and between alveolar gas and arterial blood due to the
non-uniform distribution of lung perfusion (Ayres et al., 1964). Thesum of these effects results in end-tidal to arterial gradients of less
than 50 mm Hg in healthy subjects (Ayres et al., 1964). This PO2 dif-
ference at hyperoxia would correspond to an error in calculation of
plasma O2 content of 0.15 ml per decilitre, or less than 0.7% of total
blood O2 content which would have a negligible effect on the calcula-
tion of qh. However in our study, end-tidal to arterial PO2 gradient
was reduced further by several factors unique to our method of con-
trolling the PaO2 (see Respiratory paradigm section). The employ-
ment of the sequential gas delivery circuit to administer the O2 (in
which gas in equilibrium with alveolar blood gas occupies the ana-
tomical dead space) resulted in a more homogeneous distribution in
alveolar PO2 (Swenson et al., 1994; Brogan et al., 2004; Ito et al.,
2008). This minimises the gradient between expired and alveolar
gas, and also eliminates the effect of the variability of distribution of
pulmonary blood ﬂow to PaO2 (Ito et al., 2008; Fierstra et al., 2011).
The total arterial blood oxygen content (CaO2) is the sum of the
oxygen bound to haemoglobin and that dissolved in plasma
CaO2 ¼ ϕ⋅ Hb½ ⋅SaO2ð Þ þ ε⋅PaO2 ð9Þ
where ϕ=1.34 ml(O2)/g is the oxygen carrying capacity of
haemoglobin, [Hb]=15 g/dlblood is the concentration of haemoglobin
and ε=0.0031 ml/(dlblood·mm Hg) is the solubility coefﬁcient of oxy-
gen in blood (Chiarelli et al., 2007a). Dissolved oxygen meets part of
the tissue oxygen requirement (Rostrup et al., 1995).
Venous haemoglobin oxygen saturation (SvO2) can be estimated
using the method proposed by Chiarelli et al. (2007a). The total ve-
nous blood oxygen content (CvO2) is what remains after oxygen has
been extracted from capillaries, and is given by
CvO2 ¼ CaO2−OE ð10Þ
where OE is the oxygen extraction. OE is assumed to be independent
of the level of hyperoxia, and OE=CaO2,0⋅OEF, where CaO2,0 is the
total arterial oxygen content at normoxia and OEF is the oxygen ex-
traction fraction at normoxia (=Q0). Since venous haemoglobin is
not close to being fully saturated under normobaric hyperoxia, it
can be assumed that a negligible amount of the CvO2 is carried as
dissolved oxygen. This means that Eqs. (9) and (10) can be combined
to give venous oxygen saturation:
1−Qð Þ ¼ CvO2= ϕ⋅ Hb½ ð Þ ¼
ϕ⋅ Hb½ ⋅SaO2ð Þ þ ε⋅PaO2−OE
ϕ⋅ Hb½ ð Þ ; ð11Þ
which is also plotted in Fig. 1b. This model can be used to estimate
(1−Q) from PaO2, which can be estimated by measuring exhaled
gas oxygen fraction.
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be estimated independently of OE or OEF, but Q0 must be estimated.
There are two possible ways of doing this and we have attempted
both in this paper. First the value can be taken from literature values
of OEF, (we used 0.4 here). Alternatively, in principle it can be mea-
sured from venous blood (e.g. from the T2 (Lu and Ge, 2008) or sus-
ceptibility as used here (Jain et al., 2010), see Analysis section).Materials and methods
Nine healthy volunteers (3 male, 6 female; mean age=27±
3 years, range 23–30 years) participated in this study. Ethical approv-
al was given by the University of Nottingham Medical School Ethics
Committee and all subjects gave informed written consent prior to
participating. For one subject there was a signiﬁcant change in
PETCO2 (>1 mm Hg) during the transitions into both hyperoxia pe-
riods, which overlapped with the motor trials at hyperoxia and so
this subject was discarded from further analysis.Motor paradigm
All subjects were asked to perform a motor task during a respira-
tory challenge, so that the same motor task was repeated both at
normoxia and hyperoxia. The motor task consisted of a bilateral se-
quential ﬁnger tap. This was visually cued, with the word ‘TAP’
displayed in red on a dark background on a projector screen at the
end of the magnet bore. This was replaced by a white ‘+’ ﬁxation
point during rest periods.
The respiratory challenge consisted of two repeats of 3 min of
normoxia, followed by 3 min of hyperoxia, with a ﬁnal 3 min of
normoxia at the end. The motor paradigm consisted of blocks of
two trials of 30 s ON/30 s OFF at each gas level, with the block
ﬁnishing just before the start of a transition between the two gas
levels (see Fig. 2A — Paradigm A). For the ﬁnal subject, the paradigm
was modiﬁed to maintain the subject's attention better: evenly
spaced motor trials of 90 s of rest followed by 30 s ON/60 s OFF
were superimposed on 2 min of normoxia, followed by two repeats
of 2 min hyperoxia and 4 min of normoxia (see Fig. 2B — Paradigm
B). Alternate trials fell at a respiratory transition and could not be
used, giving 4 usable trials in total.
The last 4 subjects (indicated in Table 3) were also asked to com-
plete an additional motor task during an ASL acquisition to allow the
relative change in CBF to be measured, and thus the relative change in
CMRO2 to be estimated. This task consisted of 10 trials of Paradigm A
or 8 trials of Paradigm B, performed with the subject breathing med-
ical air.Fig. 2. An illustration of the combined hyperoxia and motor task for (A) the 30 s ON/30 s O
motor task is shown in grey. Trials marked with an * were used in the analysis for (B).Respiratory paradigm
A feed-forward, low gas ﬂow system (RespirAct™, Thornhill
Research Inc., Toronto, Canada) and a sequential gas delivery (SGD)
breathing circuit (Banzett et al., 2000; Slessarev et al., 2007) were
used to target end-tidal PCO2 (PETCO2) and PO2 (PETO2) independent-
ly (Slessarev et al., 2007). Source gases used by the system were O2,
air, and two gas blends of N2, CO2 and O2, so that all source gases
contained safe concentrations of O2. The RespirAct™ follows the ap-
proach of Slessarev et al. (2007) to calculate the required ﬂows of
these source gases into the SGD breathing circuit to attain the
targeted PETCO2 and PETO2 values. For the normoxic condition, both
PETO2 and PETCO2 were maintained at the subject's resting values
(~110 mm Hg and ~40 mm Hg, respectively). For the hyperoxic con-
dition, PETO2 was targeted at 500 mm Hg, whilst PETCO2 was
maintained at the resting value.
Data acquisition
Scanning was performed on a Philips Achieva 7 T system, with
head volume transmit and 16 channel SENSE head receive coil.
Gradient echo (GE) EPI data were acquired every 2.4 s throughout
the respiratory and motor tasks. Images consisted of 2 mm isotropic
voxels, with a 192×192 mm2 ﬁeld-of-view, and 20 axial slices
(2 mm thickness, no slice gap) spanning the motor cortex. Imaging
parameters were TE=25 ms, SENSE factor=3, voxel band-width=
41.5 Hz, TR=2.4 s and ﬂip angle=75°. ASL datasets were acquired
using a FAIR labelling scheme, with TI=1400 ms, selective thickness
10 mm wider than the imaging volume, non-selective thickness of
300 mm and background suppression pulses at 402 and 639 ms
(Garcia et al., 2005); in-plane pre- and post-saturation were used.
These images consisted of 2×2×4 mm3 voxels, with a 192×
192 mm2 ﬁeld-of-view, and 8 axial slices (4 mm thickness, no slice
gap) with the same orientation and centre as the GE EPI data. Imaging
parameters were TE=14 ms, SENSE factor=3, voxel band-width=
41.5 Hz, TR=3 s (6 s for a tag/control pair). Two equilibrium
magnetisation images were acquired for signal normalisation (same
parameters as for the ASL, except with no inversion and a long TR of
10 s), one before and one after the ASL acquisition.
Analysis
GE EPI datasets were motion corrected using MCFLIRT (FSL, fMRIB,
Oxford, UK). Voxelwise linear detrending was then performed using a
linear ﬁt (MATLAB, The MathWorks, Natick, USA) to baseline
timepoints (i.e. during periods of normoxia and not within 30 s of a
previous ﬁnger tap). Linear detrending was chosen in preference toFF paradigm (Paradigm A) and (B) the 30 s ON/60 s OFF paradigm (Paradigm B). The
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digm. Maps of statistical signiﬁcance of the BOLD response to the
motor task were formed using the FEAT (FSL, fMRIB, Oxford, UK) gen-
eral linear model. This was done on the datasets before voxelwise
normalisation, but after motion correction and linear detrending. A
boxcar design, representing the hyperoxia response was included in
the model design as an independent regressor, so the hyperoxia-
based BOLD response could be separated from the motor response
in the analysis. ‘BOLD motor activation masks’ were formed of clus-
ters of voxels with Z>5 and Pclusterb0.05 for the response to the
motor task.
Since the ASL data was background suppressed, this made motion
correction problematic due to the low signal of the tag and control
images. Instead the two equilibrium magnetisation images from the
start and end of the ASL data set were subtracted to determine
whether there was any systematic motion through the dataset, and
no more than 1 voxel of displacement was found across all subjects.
The interleaved acquisition of tag and control ASL images meant
that linear temporal interpolation (MATLAB, The MathWorks, Natick,
USA) had to be performed on both the tag and control datasets. ASL
subtraction was then performed between interpolated tag and con-
trol datasets, resulting in a CBF-weighted timecourse with timepoints
every 3 s, but a real temporal resolution of 6 s. Maps of statistical sig-
niﬁcance of the CBF response to the motor task were formed using the
FEAT (FSL, fMRIB, Oxford, UK) general linear model. In this analysis, a
high-pass ﬁlter was used with a cut-off period of twice the trial
length, corresponding to 120 s for Paradigm A and 180 s for Paradigm
B. ‘CBF motor activation masks’were formed of clusters of voxels with
Z>2.3 and Pclusterb0.05. The lower Z-statistic threshold was used due
to the intrinsically lower SNR of ASL compared with GE EPI BOLD.
Timecourses of measured PETO2 were used to estimate the abso-
lute change in venous deoxyhaemoglobin fraction due to hyperoxia
(ΔQh) (see Theory section). Q0 and hence the relative change (qh)
was then calculated using an assumed resting OEF of 0.4. In addition,
in an attempt to avoid the need to assume resting OEF, phase data
constructed from the GE EPI dataset were used to calculate an alter-
native value of Q0 and hence qh. The phase data were unwrapped in
space over each volume (PRELUDE, FSL) and then unwrapped over
time (UNWRAP, MATLAB). The motion correction transformations
from the magnitude data were applied to the unwrapped phase
data (MCFLIRT, FSL). To remove the global phase shift caused by in-
creased oxygen concentrations in the frontal sinus and nasal cavity
(Driver et al., 2011; Pilkinton et al., 2011), the phase data were
high-passed ﬁltered using a homodyne ﬁlter with a smoothing kernel
with a FWHM of 4 mm (Hammond et al., 2008). The ﬁltered phase
data were then separated into normoxia and hyperoxia periods, de-
ﬁned as the ﬁnal 2 min of each period (1 min for paradigm B). A
line proﬁle was taken across the sagittal sinus, to estimate theFig. 3. Example data illustrating the phase-based calculation of Q0. Average (a) normoxia an
highlighted in red. (c) Line proﬁles for normoxia (black) and hyperoxia (red). The ﬁtted raextravascular phase shift due to dHb in the sagittal sinus both at
normoxia and hyperoxia (example in Fig. 3). A ratio of hyperoxia:
normoxia phase (a) was calculated by a least-squares ﬁt of the line
proﬁles to the equation ϕhyperoxia=a·ϕnormoxia. Voxels with a large
intravascular component (such as sagittal sinus) were excluded
from the ﬁt, by applying a high intensity threshold to the magnitude
data, averaged over the normoxia period. Assuming that the suscepti-
bilities of tissue and blood plasma are equal to that of water and that a
is also equal to the ratio of hyperoxia:normoxia susceptibilities, rela-
tive to tissue; the following equation can be used to relate a and ΔQh
to Q0 (see Appendix A):
1−Q0ð Þ ¼
ΔQh⋅ Δχoxy−Δχdeoxyð Þ
1−að Þ −Δχdeoxy
Δχoxy−Δχdeoxy
  ð12Þ
where Δχoxy=−0.017×10−6,Δχdeoxy=+0.247×10−6 (Spees et
al., 2001) are the volume susceptibilities of oxygenated haemoglobin
and deoxygenated haemoglobin relative to water, respectively.
For the GE EPI datasets each voxel's timecourse was normalised by
dividing by the average value over all baseline timepoints and then
average timecourses were calculated over all voxels within the
‘BOLD motor activation mask’. In some cases, transient changes in
PETCO2 occurred during a PETO2 transition, which persisted into the
start of the next motor trial. Any motor trial which included a change
in PETCO2 of greater than 1 mm Hg compared to the normocapnia
value was discarded. The average signal during rest and active
periods (motor task) were compared to the normoxic baseline (de-
ﬁned earlier), to estimate rest and an active % signal change
(%BOLD) for each trial and each hyperoxia/normoxia condition.
These % changes were converted to ΔR2* changes using the approxi-
mation ΔR2*≈−%BOLD/(100TE), to estimate qact. Linear regressions
(MATLAB, The MathWorks, Natick, USA) were performed to ﬁt ΔR2*
as a linear function of qh, separately for the rest and active conditions.
The ﬁtted parameters were then used to estimate qact and rvCBV, as
proposed in the Theory section.
For each of the four subjects for which ASL data were acquired an
additional ‘combined mask’ was formed from the intersection of the
‘BOLD motor activation mask’ and ‘CBF motor activation mask’. The
CBF-weighted data (after interpolation and subtraction) were
normalised to the rest periods, by dividing by the average of the last
half of all rest periods, and an average timecourse was calculated
over all voxels in the ‘combined mask’. The % change in CBF on activa-
tion was calculated by averaging over the active (motor task) period
of all trials, multiplied by 100. Values of qact were recalculated for
the ‘combined mask’ using the same method as described above,
rCBF and qact were used to calculate rCMRO2, using Eq. (7). Maps of
the pixel values of M, rvCBV and qact were also calculated.d (b) hyperoxia phase maps (range−1 to 1 rad), with the selected line proﬁle position
tio a of hypercapnia phase to normocapnia phase is shown for this subject.
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Transitions in ΔPETO2 of 330±20 mm Hg (mean±SEM over
subjects) were achieved, which corresponded to an increase of
ΔYv=0.068±0.003 and an 11% increase over the resting normoxia
value. The average change in end tidal CO2 on hyperoxia compared
to normoxia was ΔPETCO2=−0.5±0.1 mm Hg (range of −1.1–
0 mm Hg across subjects) which was assumed to be too small to
have a signiﬁcant effect on CBF and the resulting BOLD signal.
Fig. 4 shows example BOLD, PETO2 and PETCO2 timecourses for sub-
ject 3 in the ‘BOLD motor activation mask’. Averaged across all
subjects, the baseline BOLD signal increased by 6.4±0.9% with
hyperoxia and the BOLD response to the motor task was increased
by 37±7% on hyperoxia compared to normoxia. An example of an
average trial of the motor task at normoxia and hyperoxia, as well
as an example of the linear ﬁts are shown in Fig. 5. The gradients of
the linear ﬁts gave M=36±5% and M′=48±7%. Individual subject
values for the relative increase in vCBV, relative decrease in
deoxyhaemoglobin fraction qact and corresponding absolute increase
in ΔYact(=−Q0·qact) during the motor task are reported in Table 2.
Monte Carlo simulations were performed to estimate the precision
of the rvCBV and qact values; 10,000 timecourses were simulated
with the same temporal SNR (161) as the actual data and the
resulting absolute standard deviation in the estimated values was
σ(rvCBV)=4.3% and σ(qact)=2.1% with no signiﬁcant systematic
error.
An example CBF average trial timecourse is shown in Fig. 5c.
Results based on the combined mask, rCBF, qact and rCMRO2 are
reported in Table 3, for both an assumed Q0 value of 0.4 and for Q0
calculated from the phase data. For the ‘combined mask’, values of
M and M′ were calculated as M=28±2% and M′=34±2%, and
rvCBV=22±7% was lower in all four subjects compared with those
values calculated from the ‘BOLD motor activation mask’.
Voxel-by-voxel maps of M, rvCBV and qact were formed by
performing the above analysis on each voxel in the ‘combined mask’
and are shown in Fig. 6.Fig. 4. Example timecourses from a single subject for (a) BOLD, (b) PETO2 and (c) PETCO2
(BOLD motor activation mask).Discussion
This paper has described a new method of using hyperoxia to
measure CMRO2. By comparing the response to a task at hyperoxia
and normoxia it provides an extra degree of information on the vas-
cular nature of the BOLD signal. As a result, this method does not
make any assumption about the coupling between CBV and CBF, but
instead provides a direct measurement of the change in blood volume
and oxygenation on activation with relatively low sensitivity to noise
as indicated by the Monte Carlo simulations. Essentially this method
is equivalent to the previous method proposed for hyperoxia based
measurement of CMRO2 (Chiarelli et al., 2007a) except that instead
of using the Grubb relationship, here rvCBV is measured directly
(Blockley et al., 2012). Recently, hypercapnia and hyperoxia calibrat-
ed BOLD approaches have been combined to map basal OEF (Bulte et
al., 2012; Gauthier and Hoge, 2012), relying on an assumed coupling
relationship between CBV and CBF. These basal measurements could
be extended by including a hypercapnia challenge repeated both at
normoxia and hyperoxia to overcome the need to assume this
relationship.
The rCMRO2 changes measured here agree with measurements
made using hypercapnia-based calibration for a bilateral ﬁnger tap,
with rCMRO2=16±9% (Kastrup et al., 2002) and 5–45% (Chiarelli
et al., 2007b), and for a right-handed ﬁnger tap using positron emis-
sion tomography giving rCMRO2=11±13% (Ito et al., 2005). The
value of rvCBV=22±7% measured here is approximately twice that
measured for a motor task by Chen and Pike (2009). Possible reasons
for this difference could be due to differences in task performance, the
region selected or the methods themselves, and it would be interest-
ing to compare the two methods directly in future work. In this study
there was a trend for a smaller increase in rvCBV in the ‘combined
mask’ deﬁned by both BOLD and CBF activated regions, compared
with the ‘BOLD mask’. This suggests a smaller change in rvCBV in
the microvasculature, compared with draining veins that contribute
to the ‘BOLD mask’ but probably do not represent active tissue
(Leontiev et al., 2007). The ‘combined mask’ was used for the esti-
mate of CMRO2, to help to meet the extravascular signal assumption,
by excluding large draining veins, whilst focusing the ROI on areas of
active tissue.
This paper reports the ﬁrst measurements of M in humans at 7 T.
Equivalent values measured in the motor cortex are M≈4−6% at 3 T
using hyperoxia or hypercapnia (Chiarelli et al., 2007a; Chiarelli et al.,
2007b; Mark et al., 2011) and M≈5−9% at 1.5 T using hypercapnia
(Kastrup et al., 2002; Stefanovic et al., 2004, 2005, 2006). An alterna-
tive approach at 3 T, calculating M by attempting to fully saturate ve-
nous blood using combined hypercapnia and hyperoxia (10% CO2
carbogen) reported M=7.5–9.5% in the visual cortex (Gauthier et
al., 2011). The increased value reported here (M=36±5%, 8 subjects
for BOLD activated region) is consistent with the increased BOLD con-
trast at 7 T and a smaller voxel volume causing less partial voluming.
The ‘combined mask’ giving the region activated in both BOLD and
CBF gave a lower value (M=28±2%, 4 subjects), which would be
expected due to the exclusion of large draining veins from this region.
All previous calibrated BOLD experiments have assumed a cou-
pling relationship between CBV and CBF in Eq. (1), most using the re-
lationship that was originally measured in rhesus monkeys, using PET
and hypercapnia (α=0.38) (Grubb et al., 1974). However since deox-
ygenated haemoglobin is the source of BOLD contrast, the venous,
rather than total blood volume compartment should be used in the
calibrated BOLD model. The venous compartment reacts passively to
ﬂow changes, whereas the arterial compartment actively constricts
and dilates and so the coupling relationships for these two compart-
ments would be expected to be different. Furthermore the global
vascular response to a hypercapnic challenge may be different to
the local response to neuronal activity, and the coupling relationship
could change in pathology. Despite recent improvements in the
Fig. 5. (a) Average motor trial %BOLD timecourses during hyperoxia (red dashed line) and normoxia (black line). (b) Example of the linear ﬁt between R2* and (1+qh). (c) The %CBF
response to the motor task, averaged over trials. Data from subject 8, formed from the ‘combined mask’ (the intersection of BOLD and CBF motor activation masks).
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and Pike, 2009, 2010), it remains preferable to avoid use of an
assumed coupling constant.
Estimating qh from PETO2 requires an assumed value of Q0 which is
equivalent to OEF (0.4 used here; see Eq. (10) and central columns on
Table 3). OEF is thought to be fairly constant across healthy subjects,
but it may vary in patients. The estimate of OEF does not affect the es-
timated change in absolute venous blood oxygenation, ΔQh, but it will
bias the relative change qh, since this is normalised to OEF. The calcu-
lation of rvCBV is independent of errors in OEF, but a systematic error
in qact will occur, which will be linearly proportional to the error in
OEF, and this problem is common to all hyperoxia based methods of
estimating rCMRO2 that use a literature value for OEF. An alternative
approach is to estimate global OEF from venous blood oxygenation
(Lu and Ge, 2008; Jain et al., 2010). We attempted this post hoc anal-
ysis here, using the change in blood susceptibility on hyperoxia to
provide a method of estimating the baseline susceptibility in the ves-
sel independent of any model of the pattern of the ﬁeld shift around
the vessel. The variability in measured Q0 (equivalent to OEF) across
subjects from this technique is most probably dominated by errors
in the technique, such as line proﬁle selection and the underlying
quality of the phase image, rather than biological inter-subject vari-
ability. Higher resolution gradient echo images and alternative data
analysis approaches such as 2D rather than 1D proﬁles around the
vessel, are likely to provide more reliable estimates of Q0. Although
OEF is thought to be homogeneous across a healthy brain, a global
OEF measurement may not be appropriate in some vascular patholo-
gies (such as stroke), where local differences in OEF may be present,
but with improved quality phase maps it will be possible to measure
OEF more locally to the site of activation.
This work used a linear dependence of R2* on venous deoxygen-
ation (β=1) (Yablonskiy and Haacke, 1994) which assumes that
the system is in the static dephasing regime (Kennan et al., 1994).
This assumption is considered reasonable at 7 T, where larger fre-
quency shifts occur around venules compared to at lower ﬁeld
strengths (Boxerman et al., 1995). The linear correlation observedTable 2
Individual subject results for the BOLD motor activation mask ROI, showing rvCBV, qact
and ΔYact in response to the motor task.
Subject # Paradigm rvCBV (%) qact (%) ΔYact
1 A 36.8 −36.9 0.148
2 A 23.6 −56.1 0.224
3 A 33.3 −33.6 0.134
4 A 33.7 −39.9 0.160
5 A 18.7 −36.9 0.148
6 A 32.1 −31.0 0.124
7 A 30.7 −35.2 0.141
8 B 44.6 −43.4 0.174
Mean±SEM 32±3 −39±2 0.157±0.007between R2* and PETCO2 and R2* and PETO2 at 7 T (Driver et al.,
2010; Croal et al., 2012a) is consistent with this assumption. This is
an extravascular signal model, which is reasonable since the short T2*
of venous blood at 7 T (Blockley et al., 2008) means that the intravas-
cular GE signal contribution is small at TE=25 ms (Duong et al.,
2003). At the clinically accessible ﬁeld strengths of 1.5 T and 3 T,
the intravascular contribution to BOLD signal becomes signiﬁcant
and the extravascular BOLD signal includes a signiﬁcant diffusive
component, so the relationship between R2* and Q is no longer linear
(Ogawa et al., 1993; Kennan et al., 1994; Boxerman et al., 1995). An
extra compartment could be added to the BOLD signal model to
account for the intravascular signal component, or this could be
suppressed by using bipolar diffusion gradients. The supra-linear
relationship, relating R2* and Q by the power β, widely used for low
ﬁeld calibrated BOLD (Davis et al., 1998) could be adopted here
(e.g. β=1.5 at 1.5 T).
Common to any hyperoxia-based calibration study, a possible source
of error is a change in arterial blood oxygenation on hyperoxia, which
will contribute to the hyperoxia BOLD signal. Considering the changes
in arterial and venous saturations on hyperoxia illustrated in Fig. 1b,
the effect of hyperoxia on venous blood susceptibility is about ﬁve
times greater than the effect on arterial blood susceptibility. Speciﬁcally
an increase in arterial oxygen saturation of 0.017 (for oxygen partial pres-
sure PaO2 changing from110 to 500 mm Hg)will cause a decrease in vol-
ume susceptibility (less paramagnetic, smaller shift relative to tissue) of
Δχv=−0.0018×10−6 (cgs units), based on Δχv(fully deoxygenated−
fully oxygenated haemoglobin)=0.264×10−6 (Spees et al., 2001) and
a haematocrit of Hct=0.4. When this is combined with the fact that the
venous blood volume is about three times greater than the arterial
blood volume (Lee et al., 2001) this leads to approximately a 15 fold larger
effect of hyperoxia on venous blood signal than on arterial blood signal.
Assuming there is no change in arterial saturation on activation, then
this will lead to a small constant overestimation of both M and M′
which will lead to a small underestimation of rvCBV and hence qact.
In contrast, hyperoxia will also lead to an increase in dissolved
oxygen in arterial plasma which will cause an increase in arterial sus-
ceptibility (more paramagnetic, bigger shift relative to tissue). With
the amount of dissolved oxygen determined by ε⋅PaO2 in Eq. (9)
the volume susceptibility contribution of oxygen dissolved in blood
plasma is given by:
χv PaO2ð Þ ¼
χm
Vm  103
⋅ε⋅PaO2 ð13Þ
where ε=0.0031 ml/(dlblood·mm Hg) is the solubility coefﬁcient of
oxygen in blood, χm=+3415×10−6cm3 mol−1 (CRC, 2010) is the
molar susceptibility of oxygen (cgs units) and Vm=24.5 L/mol is the
molar volume, the volume occupied by 1 mol of ideal gas at room
temperature and atmospheric pressure. Therefore the contribution of
Table 3
Individual subject results for the ‘combined mask’, including results using both an assumed Q0=0.4 and results estimated from phase measurements of Q0.
Subject # Paradigm rCBF (%) ΔYact Assumed Q0=0.4: Measured Q0:
qact (%) rCMRO2 (%) Q0 qact (%) rCMRO2 (%)
5 A 58.0 0.116 −29.0 12.2 0.424 −27.4 14.8
6 A 57.8 0.119 −29.8 10.9 0.487 −24.4 19.3
7 A 87.2 0.103 −25.8 39.0 0.381 −27.0 36.7
8 B 87.4 0.164 −40.9 10.7 0.346 −47.3 −1.1
Mean±SEM 73±10 0.125±0.015 −31±4 18±8 0.410±0.035 −32±6 17±9
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0.0005×10−6 at normoxia and χv(PaO2=500 mm Hg)=0.0022×
10−6 at hyperoxia (cgs units). The resulting increase in susceptibility
of Δχv=+0.0017×10−6 will cause a small overestimation of rvCBV
and qact, partially cancelling the underestimation of rvCBV and qact pre-
dicted in the previous paragraph due to increased arterial haemoglobin
saturation with hyperoxia. To put both these changes in arterial suscep-
tibility in context, the estimated change in venous oxygenation satura-
tion of 0.068±0.003 due to hyperoxia and 0.14±0.01 due to the
motor task will correspond to a susceptibility change of 0.0072×10−6
and 0.0148×10−6 respectively (cgs units).
If the arterial blood volume changes on activation, this will also
cause a change in signal on activation that is unaffected by hyperoxia,
leading to an error in the estimate of qact (but not in rvCBV). Consid-
ering the relative changes in the arterial and venous blood volumes,
and the T2* of arterial and venous blood and tissue, it is estimated
that this will have an effect of about 5% on the difference in the inter-
cepts in Fig. 1a that is used to estimate qact.
The model used here assumes that qact is the same at both
normoxia and hyperoxia which in turn assumes negligible changes
in both CBF and CMRO2 on hyperoxia. The effect of hyperoxia on va-
soconstriction and CBF is a matter of debate in the literature. Studies
measuring CBF during hyperoxia have used ﬁxed inspired gas mix-
tures to induce hyperoxia, and showed a decrease in CBF with
hyperoxia (Kety and Schmidt, 1948; Watson et al., 2000; Kolbitsch
et al., 2002; Bulte et al., 2007b). Attempts have been made to correct
for this CBF decrease based on a look up table (Chiarelli et al., 2007a).
However, as well as hyperoxia, these ﬁxed inspired gas mixtures
cause hypocapnia (reduced PETCO2), which will cause a decrease in
CBF. Graded hypercapnia has been used to try to separate hypocapnic
from hyperoxic effects on CBF, measured using continuous-ASL
(Floyd et al., 2003), ﬁnding a decrease in CBF with hyperoxia. Howev-
er, in more recent work (Zaharchuk et al., 2008), the apparent de-
crease in CBF measured by continuous-ASL was mostly accounted
for by a change in arterial blood T1 due to hyperoxia, rather than an
actual CBF decrease. Recent work has found no change in global CBF
on hyperoxia, when maintaining isocapnia during hyperoxia and
measuring ﬂow using phase contrast MRI (which is insensitive to T1
changes) and arterial CBV (Croal et al., 2012b). The effect of hyperoxiaFig. 6. Voxelwise maps of M, rvCBV and qact across the combined mon CMRO2 has not been addressed in the literature and needs further
investigation.
In this experiment, the change in PETCO2 during hyperoxia was −
0.5±0.1 mm Hg, less than that for an equivalent ﬁxed inspired
hyperoxia method (ΔPETCO2≈−3 mm Hg during a 60% O2 challenge
(Bulte et al., 2007b)). The effect on CBF and resulting BOLD signal is
expected to be insigniﬁcant (~2% decrease for CBF (Noth et al., 2006)
and ~0.2% decrease for BOLD (Driver et al., 2010)). However, in this
study a brief overshoot in PETCO2 of 1–2 mm Hg occurred during the
transition to hyperoxia. In most cases this overshoot recovered back to
baseline by the time of the motor task, but it did overlap with some
motor trials, which were therefore discarded. It is likely that the
RespirAct™ algorithm could bemodiﬁed tominimise this effect. Howev-
er, any method inducing hyperoxia whilst maintaining isocapnia would
be suitable for this technique.
The susceptibility difference at the air–tissue interface in the oral
cavity and frontal sinus will increase on hyperoxia, leading to increased
ﬁeld inhomogeneity across the brain (Blockley et al., 2009; Pilkinton et
al., 2011), which will be worse at higher ﬁeld strengths. Changing the
oxygen fraction of air from21 to60%O2 changes the volume susceptibility
of air by Δχv=0.054×10−6 (cgs units, assuming χm(O2)=+3415×
10−6cm3 mol−1 and χm(N2)=−12×10−6cm3 mol−1 (CRC, 2010)).
For the EPI acquisition used here, the resulting change in ﬁeld inho-
mogeneity has been shown to cause image distortion and intra-voxel
dephasing close to the frontal sinus, but to have small effects in the
motor cortex that would not signiﬁcantly affect the results presented
here (Driver et al., 2011).
Conclusions
A new approach to BOLD calibration has been proposed and
implemented, where a task is performed both at normoxia and
hyperoxia. This uses hyperoxic BOLD contrast to estimate the change
in venous blood oxygenation and venous CBV during a motor task.
OEF was estimated from the phase data, allowing the effect of
hyperoxia on venous blood oxygenation to be estimated on a subject
by subject basis. By including an ASL measurement, the relative
change in CMRO2 was estimated. The measured change in CMRO2
agrees with previous work, using other methods, but unlike thoseask (the intersection of BOLD and CBF motor activation masks).
1186 I.D. Driver et al. / NeuroImage 63 (2012) 1178–1187methods, this approach does not assume a poorly characterised rela-
tionship between vCBV and CBF.
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Appendix A
Eq. (12), which allows Q0 to be estimated from the ratio of phase
change between hyperoxia and normoxia and ΔQh, is derived as
follows. The assumption is made that on the unwrapped, ﬁltered
phase data, the phase shift in the region immediately around the sag-
ittal sinus is dominated by the susceptibility of the blood in the sagit-
tal sinus so
a ¼ ϕHO
ϕNO
¼ χHO
χNO
ðA:1Þ
where χ is the susceptibility of the sagittal sinus relative to tissue, and
the subscripts denote the hyperoxia (HO) and normoxia (NO) condi-
tions. This equation makes no assumptions about the spatial nature of
the ﬁeld shift around the vein, only that the ﬁeld shift around the vein
is dominated by the vein and is proportional to the deoxygenation of
the vein. Assuming that blood plasma and tissue have the same sus-
ceptibility as water, the sagittal sinus susceptibility can be related to
blood oxygenation (Y) by:
χNO ¼ Hct Y⋅Δχoxy þ 1−Yð Þ⋅Δχdeoxy
 
ðA:2Þ
χHO ¼ Hct Yþ ΔYhð Þ⋅Δχoxy þ 1−Y−ΔYhð Þ⋅Δχdeoxy
 
ðA:3Þ
where Hct is the haematocrit fraction and ΔYh=−ΔQh. Eqs. (A.2)
and (A.3) can be combined using Eq. (A.1), and be rearranged to give
Y ¼
−ΔYh⋅ Δχoxy−Δχdeoxyð Þ
1−að Þ −Δχdeoxy
Δχoxy−Δχdeoxy
  : ðA:4Þ
Blood oxygenation fractions can be converted to dHb fractions by
substituting Y=(1−Q) and ΔYh=−ΔQh, giving Eq. (12).
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